bendazac

Known as: 1-benzylindazole-3-oxyacetic acid, bendazolic acid, bindazac 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1968-2013
024619682013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Drug-induced liver injury (DILI) is a significant consideration for drug development. Current preclinical DILI assessment relying… (More)
Is this relevant?
1995
1995
Bendazac has been used as an anti-cataractogenic drug. It has been reported that this acts by preventing protein denaturation. In… (More)
Is this relevant?
1994
1994
Ocular and systemic absorption of bendazac was investigated after topical administration to rabbits of 0.5% solutions of bendazac… (More)
Is this relevant?
1990
1990
It is conceivable that drugs with anticataract potential possess antioxidant activity. Using defined chelating agents and… (More)
Is this relevant?
1988
1988
Enhanced non-enzymic glycation of proteins has been suggested to play a role in the pathogenesis of diabetic microangiopathy… (More)
Is this relevant?
1988
1988
Glucose-6-phosphate and galactose react non-enzymically with lens proteins. The rates of these reactions are decreased by 5… (More)
Is this relevant?
1987
1987
The compounds silibin, sorbinil and bendazac act as hydroxyl radical scavengers, when the hydroxyl radical is generated by the… (More)
Is this relevant?
1987
1987
The pharmacokinetics of bendazac and its major metabolite, 5-hydroxybendazac, have been investigated in 15 patients with moderate… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1983
1983
The plasma levels of the lysine salt of bendazac were studied in man after repeated administrations. The substance was… (More)
Is this relevant?
1983
1983
Bendazac, as such or in the form of its l-lysine salt, has a protective effect against lens protein denaturation both in vitro… (More)
Is this relevant?